Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

** = Publikationen gelistet in SCI/SSCI/Pubmed

** Sourij, H; Azhar, K; Aziz, F; Kojzar, H; Sourij, C; Fasching, P; Clodi, M; Ludvik, B; Mader, JK; Resl, M; Rega-Kaun, G; Ress, C; Stechemesser, L; Stingl, H; Tripolt, NJ; Wascher, T; Kaser, S Interplay of health-related quality of life and comorbidities in people with type 2 diabetes mellitus treated in primary care settings in Austria: a countrywide cross-sectional study.
BMJ Open. 2025; 15(4):e092951 Doi: 10.1136/bmjopen-2024-092951 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Sourij, H; Azhar, K; Aziz, F; Kojzar, H; Sourij, C; Fasching, P; Clodi, M; Ludvik, B; Mader, JK; Resl, M; Rega-Kaun, G; Ress, C; Stechemesser, L; Stingl, H; Tripolt, NJ; Wascher, T; Kaser, S Metabolic risk factor targets in relation to clinical characteristics and comorbidities among individuals with type 2 diabetes treated in primary care - The countrywide cross-sectional AUSTRO-PROFIT study.
Diabetes Obes Metab. 2025; 27(1): 111-122. Doi: 10.1111/dom.15988 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Azhar, K; Ramirez-Obermayer, A; Sourij, C; Knoll, L; Andritz, E; Kojzar, H; Müller, A; Moser, O; Tripolt, NJ; Pferschy, PN; Aziz, F; Sourij, H Sustained weight reduction following 12 weeks of intermittent fasting intervention in people with insulin-treated type 2 diabetes-Two-year follow-up of the randomised controlled InterFast-2 trial.
Diabetes Obes Metab. 2025; 27(3):1605-1608 Doi: 10.1111/dom.16158 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

** Sourij, H; Azhar, K; Aberer, F; Sourij, C; Tripolt, NJ; Kojzar, H; Pferschy, PN; Buchmann, A; Aziz, F; Khalil, M Impact of level 2 hypoglycaemia on neuroaxonal damage biomarker in individuals with type 2 diabetes: A stepwise hypoglycaemic clamp study.
Diabetes Obes Metab. 2025; Doi: 10.1111/dom.16340 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG